NCT07141563View on ClinicalTrials.gov

A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC

Enrolling by invitationOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

May 26, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Non-small Cell Lung Cancer (NSCLC)
Interventions
DRUG

Nivolumab + platinum-based chemotherapy

According to the product label

Trial Locations (1)

C1426CPU

Grupo Argentino Oncología Torácica (GAOT) - Asociación Argentina Oncología Clínica (AAOC), Buenos Aires

Sponsors
All Listed Sponsors
collaborator

Grupo Argentino Oncología Torácica (GAOT) - Asociación Argentina Oncología Clínica (AAOC)

UNKNOWN

lead

Bristol-Myers Squibb

INDUSTRY